Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Dec 03, 2021 11:24am
474 Views
Post# 34194977

RE:RE:Finance question

RE:RE:Finance questionSkys, they always said they would commence Phase 1b trials on GBM and NSCLC when Phase II "was well underway". That is a subjective phrase but it could be when they receive BTD which could be very near. Then as you say that's when St. Mikes/Unity may come into play and who knows maybe they already have a deal based on getting that approval - which of course wouldn't be released until then.

Looks like people are finally catching on anyways.


skys1 wrote: DJDawg, the answer to your question is quite simple. They didn't renew the warrants and withdrew the Shelf was because they know they now have a funding source they didn't have before. My guess it's St Mikes/Unity Health, but keep in mind they have enough cash to get them through Ph 2, so it could be a while before we find out unless they file a new indication, which is a strong possibility. Then they would need additional funds.


<< Previous
Bullboard Posts
Next >>